Skip to main content

Spinal Cord Injuries (SCI)

0
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Pins Medical
Pins MedicalChina - Beijing
1 program
BCI-SCS-EXSN/A1 trial
Active Trials
NCT06939660Recruiting3Est. Apr 2027
Medtronic
MedtronicNJ - Phillipsburg
1 program
Epidural Electrical StimulationN/A1 trial
Active Trials
NCT06847295Recruiting10Est. Jan 2027
Liberate Medical
Liberate MedicalKY - Crestwood
1 program
Respiratory Muscle StimulatorN/A1 trial
Active Trials
NCT07626931Not Yet Recruiting150Est. Jun 2028

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
2028
Liberate MedicalRespiratory Muscle Stimulator
Pins MedicalBCI-SCS-EXS
MedtronicEpidural Electrical Stimulation

Clinical Trials (3)

Total enrollment: 163 patients across 3 trials

NCT07626931Liberate MedicalRespiratory Muscle Stimulator

Abdominal Stimulation to Improve Cough After Spinal Cord Injury

Start: Aug 2026Est. completion: Jun 2028150 patients
N/ANot Yet Recruiting

BCI-Assisted SCS-EXS for Gait Optimization

Start: Apr 2025Est. completion: Apr 20273 patients
N/ARecruiting
NCT06847295MedtronicEpidural Electrical Stimulation

Epidural Electrical Stimulation to Restore Standing and Walking in Patients With Chronic Paralysis Due to Spinal Cord Injury: A Study on Motor Recovery, Spasticity Reduction, and Quality of Life Improvement Through Neuromodulation and Intensive Rehabilitation

Start: Jan 2022Est. completion: Jan 202710 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 163 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.